Claims for Patent: 7,799,906

Summary for Patent: 7,799,906

Title:	Compositions and methods for modulating lignin of a plant
Abstract:	Novel plant monolignol synthesis, monolignol transport, and lignin polymerization genes and polypeptides encoded by such genes are provided. These genes and polynucleotide sequences are useful regulating the lignification process and plant phenotype. Moreover, these genes are useful for expression profiling of plant monolignol synthesis, monolignol transport, and lignin polymerization genes. The invention specifically provides polynucleotide and polypeptide sequences isolated from Eucalyptus and Pinus.
Inventor(s):	Rottmann; William H. (Summerville, SC), Connett; Marie B. (Canberra, AU), Bloksberg; Leonard N. (Auckland, NZ), Forster; Richard L. (Auckland, NZ)
Assignee:	Arborgen, LLC (Summerville, SC)
Application Number:	10/946,644
Patent Claims:	1. An isolated polynucleotide comprising a nucleic acid sequence encoding SEQ ID NO: 442 or a conservative variant of SEQ ID NO: 442, wherein the conservative variant has a sequence identity that is greater than or equal to 95% to SEQ ID NO: 442, and has the same functional properties of the polypeptide of SEQ ID NO: 442. 2. A DNA construct comprising at least one polynucleotide according to claim 1. 3. The DNA construct of claim 2, further comprising a promoter, wherein the promoter and polynucleotide are operably linked. 4. The DNA construct of claim 3, wherein the DNA construct further comprises an intron, wherein the polynucleotide, the promoter and the intron are operably linked. 5. The DNA construct of claim 2, wherein the polynucleotide encodes an RNA transcript. 6. The DNA construct of claim 3, wherein the polynucleotide is in a sense or antisense orientation relative to the promoter. 7. The DNA construct of claim 5, wherein the RNA transcript induces RNA interference. 8. A plant cell transformed with the DNA construct of claim 2. 9. A transgenic plant comprising the plant cell of claim 8. 10. The transgenic plant of claim 9, wherein a phenotype of the plant is different from a phenotype of a plant of the same species that has not been transformed with the DNA construct. 11. The transgenic plant of claim 10, wherein a phenotype that is different in the transgenic plant is the production and incorporation of syringyl monomer in lignin, and wherein the wild-type plant is characterized by lignin with little to no syringyl monomers. 12. The transgenic plant of claim 9, wherein the plant is a woody plant. 13. The transgenic plant of claim 12, wherein the plant is a tree. 14. Wood obtained from a transgenic tree which has been transformed with the DNA construct of claim 2, wherein the wood comprises said DNA construct. 15. The isolated polynucleotide of claim 1 comprising a nucleic acid encoding SEQ ID NO: 442. 16. The isolated polynucleotide of claim 1 comprising the nucleotide sequence set forth in SEQ ID NO: 190 or SEQ ID NO: 191.

Details for Patent 7,799,906

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-03-29